163 related articles for article (PubMed ID: 1869725)
1. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.
Hirshfeld JW; Schwartz JS; Jugo R; MacDonald RG; Goldberg S; Savage MP; Bass TA; Vetrovec G; Cowley M; Taussig AS
J Am Coll Cardiol; 1991 Sep; 18(3):647-56. PubMed ID: 1869725
[TBL] [Abstract][Full Text] [Related]
2. Can restenosis after coronary angioplasty be predicted from clinical variables?
Weintraub WS; Kosinski AS; Brown CL; King SB
J Am Coll Cardiol; 1993 Jan; 21(1):6-14. PubMed ID: 8417077
[TBL] [Abstract][Full Text] [Related]
3. Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables.
Renkin J; Melin J; Robert A; Richelle F; Bachy JL; Col J; Detry JM; Wijns W
J Am Coll Cardiol; 1990 Nov; 16(6):1333-40. PubMed ID: 2229783
[TBL] [Abstract][Full Text] [Related]
4. Clinical and angiographic determinants of primary coronary angioplasty success. M-HEART Investigators.
Savage MP; Goldberg S; Hirshfeld JW; Bass TA; MacDonald RG; Margolis JR; Taussig AS; Vetrovec G; Whitworth HB; Zalewski A
J Am Coll Cardiol; 1991 Jan; 17(1):22-8. PubMed ID: 1987229
[TBL] [Abstract][Full Text] [Related]
5. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
6. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.
Bourassa MG; Lespérance J; Eastwood C; Schwartz L; Côté G; Kazim F; Hudon G
J Am Coll Cardiol; 1991 Aug; 18(2):368-76. PubMed ID: 1856404
[TBL] [Abstract][Full Text] [Related]
7. Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis.
Beatt KJ; Serruys PW; Luijten HE; Rensing BJ; Suryapranata H; de Feyter P; van den Brand M; Laarman GJ; Roelandt J
J Am Coll Cardiol; 1992 Feb; 19(2):258-66. PubMed ID: 1732350
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous transluminal coronary angioplasty of the left coronary artery in patients with chronic occlusion of the right coronary artery: clinical and functional results.
De Bruyne B; Renkin J; Col J; Wijns W
Am Heart J; 1991 Aug; 122(2):415-22. PubMed ID: 1858620
[TBL] [Abstract][Full Text] [Related]
9. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis.
Gibson CM; Kuntz RE; Nobuyoshi M; Rosner B; Baim DS
Circulation; 1993 Apr; 87(4):1123-9. PubMed ID: 8462141
[TBL] [Abstract][Full Text] [Related]
10. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
11. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery.
Adelman AG; Cohen EA; Kimball BP; Bonan R; Ricci DR; Webb JG; Laramee L; Barbeau G; Traboulsi M; Corbett BN
N Engl J Med; 1993 Jul; 329(4):228-33. PubMed ID: 8316267
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous transluminal coronary angioplasty of the very proximal left anterior descending artery lesions: immediate results and follow-up.
Piovaccari G; Fattori R; Marzocchi A; Marrozzini C; Prati F; Magnani B
Int J Cardiol; 1991 Feb; 30(2):151-5. PubMed ID: 2010237
[TBL] [Abstract][Full Text] [Related]
13. [Repeat coronary angioplasty in the treatment of restenosis. Results and follow-up].
Alfonso F; Macaya C; Iñiguez A; Zarco P
Rev Esp Cardiol; 1989; 42(6):367-76. PubMed ID: 2528194
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181
[TBL] [Abstract][Full Text] [Related]
15. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
Bauters C; Mc Fadden EP; Lablanche JM; Quandalle P; Bertrand ME
Circulation; 1993 Sep; 88(3):969-74. PubMed ID: 8353924
[TBL] [Abstract][Full Text] [Related]
16. Restenosis after coronary angioplasty.
Anderson HV
Dis Mon; 1993 Sep; 39(9):613-70. PubMed ID: 8359109
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.
Pepine CJ; Hirshfeld JW; Macdonald RG; Henderson MA; Bass TA; Goldberg S; Savage MP; Vetrovec G; Cowley M; Taussig AS
Circulation; 1990 Jun; 81(6):1753-61. PubMed ID: 2188753
[TBL] [Abstract][Full Text] [Related]
18. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.
Faxon DP
J Am Coll Cardiol; 1995 Feb; 25(2):362-9. PubMed ID: 7829789
[TBL] [Abstract][Full Text] [Related]
19. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
[TBL] [Abstract][Full Text] [Related]
20. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors].
Sakai Y; Tomobuchi Y; Hashizume T; Imanishi T; Tomimoto S; Toyoda Y; Arita M; Hano T; Nishio I
J Cardiol; 1997 Jan; 29(1):1-6. PubMed ID: 9023673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
